New patent for Astrazeneca Ab drug BYDUREON PEN

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fi…


New patent for Astrazeneca Ab drug BYDUREON

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared first on D…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog